Showing results (221-230 of 229) with videos related to
Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid ModelAlicja Urbaniak, Billie Heflin, Eric Siegel, et al.Nature Communications|January 19, 2024
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growthFumou Sun, Yan Cheng, Visanu Wanchai, et al.Head & Neck|March 11, 2022
American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatmentDavid C Shonka, Alan Ho, Ashish V Chintakuntlawar, et al.JAMA Otolaryngology-- Head & Neck Surgery|January 12, 2023
Emerging Imaging Technologies for Parathyroid Gland Identification and Vascular Assessment in Thyroid Surgery: A Review From the American Head and Neck Society Endocrine Surgery SectionAmanda L Silver Karcioglu, Frédéric Triponez, Carmen C Solórzano, et al.Head & Neck|March 9, 2022
Pediatric intraoperative nerve monitoring during thyroid surgery: A review from the American Head and Neck Society Endocrine Surgery Section and the International Neural Monitoring Study GroupGillian R Diercks, Jeff C Rastatter, Ken Kazahaya, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival AnalysisAmanda N Fader, Dana M Roque, Eric Siegel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neuAmanda N Fader, Dana M Roque, Eric Siegel, et al.Head & Neck|December 23, 2021
Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies AssociationLisa A Orloff, Julia E Noel, Brendan C Stack, et al.The Laryngoscope|October 7, 2018
International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic dataChe-Wei Wu, Gianlorenzo Dionigi, Marcin Barczynski, et al.Pageof 23